Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2

por Mackin, Samantha R., Desai, Pritesh, Whitener, Bradley M., Karl, Courtney E., Liu, Meizi, Baric, Ralph S., Edwards, Darin K., Chicz, Taras M., McNamara, Ryan P., Alter, Galit, Diamond, Michael S.
Publicado 2022

prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis

por A. Dowd, Kimberly, Sirohi, Devika, D. Speer, Scott, VanBlargan, Laura A., Chen, Rita E., Mukherjee, Swati, Whitener, Bradley M., Govero, Jennifer, Aleshnick, Maya, Larman, Bridget, Sukupolvi-Petty, Soila, Sevvana, Madhumati, Miller, Andrew S., Klose, Thomas, Zheng, Aihua, Koenig, Scott, Kielian, Margaret, Kuhn, Richard J., Diamond, Michael S., Pierson, Theodore C.
Publicado 2023

A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope

por VanBlargan, Laura A., Adams, Lucas J., Liu, Zhuoming, Chen, Rita E., Gilchuk, Pavlo, Raju, Saravanan, Smith, Brittany K., Zhao, Haiyan, Case, James Brett, Winkler, Emma S., Whitener, Bradley M., Droit, Lindsay, Aziati, Ishmael D., Bricker, Traci L., Joshi, Astha, Shi, Pei-Yong, Creanga, Adrian, Pegu, Amarendra, Handley, Scott A., Wang, David, Boon, Adrianus C.M., Crowe, James E., Whelan, Sean P.J., Fremont, Daved H., Diamond, Michael S.
Publicado 2021